Skip to main content
. 2022 May 31;4:47. Originally published 2019 Mar 8. [Version 3] doi: 10.12688/wellcomeopenres.15141.3

Figure 3. Overlay of ceftriaxone at LLOQ concentration containing internal standard (2 µg/ml) and the first blank injection after injecting five ULOQ samples, presenting no significant carry-over.

Figure 3.